105 related articles for article (PubMed ID: 11173548)
1. Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: a model of tumor prevention and treatment in immune-compromised patients.
Yano T; Ishikura H; Kato H; Ogawa Y; Kondo S; Kato H; Yoshiki T
Jpn J Cancer Res; 2001 Jan; 92(1):83-7. PubMed ID: 11173548
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression.
Saito K; Ishikura H; Kishimoto T; Kawarada Y; Yano T; Takahashi T; Kato H; Yoshiki T
Int J Cancer; 1998 Jan; 75(2):284-9. PubMed ID: 9462720
[TBL] [Abstract][Full Text] [Related]
3. [The effect of IL-6 produced by pancreatic carcinoma cells on blood-borne metastasis to the liver: a study on in vivo nude mouse model].
Saito K
Hokkaido Igaku Zasshi; 1997 Jul; 72(4):397-408. PubMed ID: 9378458
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts.
Ishiguro H; Kishimoto T; Furuya M; Nagai Y; Watanabe T; Ishikura H
Cancer Immunol Immunother; 2005 Dec; 54(12):1191-9. PubMed ID: 15846489
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
6. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
Yamaji H; Iizasa T; Koh E; Suzuki M; Otsuji M; Chang H; Motohashi S; Yokoi S; Hiroshima K; Tagawa M; Nakayama T; Fujisawa T
Cancer Immunol Immunother; 2004 Sep; 53(9):786-92. PubMed ID: 15185009
[TBL] [Abstract][Full Text] [Related]
7. Inducing a humoral immune response to pancreatic cancer antigen.
Seifert M; Seifert G; Wolff-Vorbeck G; Langenmair E; Hopt UT; Wittel UA
Cell Immunol; 2016 Dec; 310():150-155. PubMed ID: 27663207
[TBL] [Abstract][Full Text] [Related]
8. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
[TBL] [Abstract][Full Text] [Related]
9. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.
Smith PC; Keller ET
Prostate; 2001 Jun; 48(1):47-53. PubMed ID: 11391686
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu.
Jasinska J; Wagner S; Radauer C; Sedivy R; Brodowicz T; Wiltschke C; Breiteneder H; Pehamberger H; Scheiner O; Wiedermann U; Zielinski CC
Int J Cancer; 2003 Dec; 107(6):976-83. PubMed ID: 14601058
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of blood-borne metastasis in relation to the interaction between pancreatic carcinoma and endothelial cells].
Kishimoto T; Saito K; Ishikura H
Nihon Rinsho; 1995 Jul; 53(7):1765-9. PubMed ID: 7630017
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen.
Kishimoto T; Ishikura H; Kimura C; Takahashi T; Kato H; Yoshiki T
Int J Cancer; 1996 Aug; 69(4):290-4. PubMed ID: 8797870
[TBL] [Abstract][Full Text] [Related]
13. Antibody induction directed against the tumor-associated MUC4 glycoprotein.
Cai H; Palitzsch B; Hartmann S; Stergiou N; Kunz H; Schmitt E; Westerlind U
Chembiochem; 2015 Apr; 16(6):959-67. PubMed ID: 25755023
[TBL] [Abstract][Full Text] [Related]
14. [LAK sensitivity of human pancreas carcinoma cell lines].
Sugiura H
Hokkaido Igaku Zasshi; 1993 Nov; 68(6):921-34. PubMed ID: 7906667
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
17. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643
[TBL] [Abstract][Full Text] [Related]
18. IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases.
Rodolfo M; Melani C; Zilocchi C; Cappetti B; Luison E; Arioli I; Parenza M; Canevari S; Colombo MP
Cancer Res; 1998 Dec; 58(24):5812-7. PubMed ID: 9865740
[TBL] [Abstract][Full Text] [Related]
19. The immunotherapeutic effect of dendritic cells vaccine modified with interleukin-18 gene and tumor cell lysate on mice with pancreatic carcinoma.
Tang ZH; Qiu WH; Wu GS; Yang XP; Zou SQ; Qiu FZ
World J Gastroenterol; 2002 Oct; 8(5):908-12. PubMed ID: 12378640
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
